Harvest Fund Management’s Zimmer Biomet ZBH Stock Holding History

Harvest Fund Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-517	Closed	-$59K	–	617
2020 Q2	$59K	Buy	+517	New	+$59.6K	0.01%	311

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Harvest Fund Management's ZBH Position: Q3 2020 in Review

Harvest Fund Management sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 517 shares — an estimated $59K sold.

Harvest Fund Management first reported a position in ZBH in Q2 2020 and held it in 1 quarter. The position peaked at $59K in Q2 2020. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Harvest Fund Management reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Harvest Fund Management sold 517 Zimmer Biomet shares in Q3 2020, an estimated $59K.
Harvest Fund Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 1 quarter.
Harvest Fund Management's Zimmer Biomet position peaked at $59K in Q2 2020.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Harvest Fund Management's 13F filing for Q3 2020, filed 4 Nov 2020.